Masahiro Tabata - Concepedia

Author

Masahiro Tabata

Also Known As

Eiki Ichihara, K. Hotta, M Tabata, M. Tabata, MASAHIRO TABATA, Masahiro TABATA, Masahiro Tabata, R D Scott, T Yonei, Tabata, Masahiro

341

Publications

5.8K

Citations

H-Index

Concepts

All Affiliations

Okayama University Okayama University Hospital Shikoku Cancer Center Okayama Medical Center Kawasaki Medical School

About

Masahiro Tabata is an author at Okayama University specializing in lung cancer, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	67	2.2K
2	Cell Biology	15	21	615
3	Health Sciences	14	17	447
4	Biochemistry	1	1	17
5	Cellular Therapies	1	1	15

Masahiro Tabata

110

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
The Relationship between Epidermal Growth Factor Receptor Mutations and Clinicopathologic Features in Non–Small Cell Lung Cancers Masaki Tokumo, Shinichi Toyooka, Katsuyuki Kiura, Clinical Cancer Research	2005	495
Phase III Trial Comparing Docetaxel and Cisplatin Combination Chemotherapy With Mitomycin, Vindesine, and Cisplatin Combination Chemotherapy With Concurrent Thoracic Radiotherapy in Locally Advanced Non–Small-Cell Lung Cancer: OLCSG 0007 Yoshihiko Segawa, Katsuyuki Kiura, Nagio Takigawa, Journal of Clinical Oncology	2010	246
Identification of Epigenetic Aberrant Promoter Methylation in Serum DNA Is Useful for Early Detection of Lung Cancer Keiichi Fujiwara, Nobukazu Fujimoto, Masahiro Tabata, Clinical Cancer Research	2005	202
Effect of gefitinib (‘Iressa’, ZD1839) on brain metastases in patients with advanced non-small-cell lung cancer Katsuyuki Hotta, Katsuyuki Kiura, Hiroshi Ueoka, Lung Cancer Brain MetastasesMedicinePathology‘ Iressa ’Bronchial Neoplasm	2004	178
Complementary roles of pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in diagnosis and prognosis of small-cell lung cancer (SCLC) Takuo Shibayama, Hiroshi Ueoka, Kenji Nishii, Lung Cancer MedicinePathologyPulmonary PharmacologyBronchial NeoplasmComplementary Roles	2001	149
Association of serum endoglin with metastasis in patients with colorectal, breast, and other solid tumors, and suppressive effect of chemotherapy on the serum endoglin. Noriko Takahashi, Rika Kawanishi‐Tabata, Akinao Haba, PubMed Surgical OncologyImmunologyPathologyOther Solid TumorsImmunotherapy	2001	123
Phase II Trial of Gefitinib in Combination with Bevacizumab as First-Line Therapy for Advanced Non–Small Cell Lung Cancer with Activating EGFR Gene Mutations: The Okayama Lung Cancer Study Group Trial 1001 Eiki Ichihara, Katsuyuki Hotta, Naoyuki Nogami, Journal of Thoracic Oncology First-line TherapyPhase Ii TrialMedicinePathologyBronchial Neoplasm	2015	103
Thrombocytosis as a Useful Prognostic Indicator in Patients with Lung Cancer Keisuke Aoe, Akio Hiraki, Hiroshi Ueoka, Respiration	2004	97
Interstitial Lung Disease in Japanese Patients With Non-Small Cell Lung Cancer Receiving Gefitinib Katsuyuki Hotta, Katsuyuki Kiura, Masahiro Tabata, The Cancer Journal	2005	75
The effect and safety of immune checkpoint inhibitor rechallenge in non-small cell lung cancer Hiromi Watanabe, Toshio Kubo, Kiichiro Ninomiya, Japanese Journal of Clinical Oncology	2019	74

Page 1